These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23621751)

  • 41. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
    Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
    Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    Woo S; Kim SY; Cho JY; Kim SH
    AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.
    Kim CK; Park SY; Park JJ; Park BK
    AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
    Mazaheri Y; Shukla-Dave A; Goldman DA; Moskowitz CS; Takeda T; Reuter VE; Akin O; Hricak H
    Magn Reson Imaging; 2019 Jan; 55():93-102. PubMed ID: 30176373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    J Magn Reson Imaging; 2009 Jun; 29(6):1360-6. PubMed ID: 19472393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
    Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
    AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
    Shinmoto H; Tamura C; Soga S; Shiomi E; Yoshihara N; Kaji T; Mulkern RV
    AJR Am J Roentgenol; 2012 Oct; 199(4):W496-500. PubMed ID: 22997399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
    Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
    AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues.
    Tamada T; Sone T; Toshimitsu S; Imai S; Jo Y; Yoshida K; Yamamoto A; Yamashita T; Egashira N; Nagai K; Fukunaga M
    J Magn Reson Imaging; 2008 Mar; 27(3):552-6. PubMed ID: 18219616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software.
    Le Nobin J; Orczyk C; Deng FM; Melamed J; Rusinek H; Taneja SS; Rosenkrantz AB
    BJU Int; 2014 Dec; 114(6b):E105-E112. PubMed ID: 24673731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.
    Wibmer A; Hricak H; Gondo T; Matsumoto K; Veeraraghavan H; Fehr D; Zheng J; Goldman D; Moskowitz C; Fine SW; Reuter VE; Eastham J; Sala E; Vargas HA
    Eur Radiol; 2015 Oct; 25(10):2840-50. PubMed ID: 25991476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.
    Rosenkrantz AB; Triolo MJ; Melamed J; Rusinek H; Taneja SS; Deng FM
    J Magn Reson Imaging; 2015 Mar; 41(3):708-14. PubMed ID: 24616064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.
    Reynolds HM; Tadimalla S; Wang YF; Montazerolghaem M; Sun Y; Williams S; Mitchell C; Finnegan ME; Murphy DG; Haworth A
    Cancer Imaging; 2022 Dec; 22(1):71. PubMed ID: 36536464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Oto A; Kayhan A; Jiang Y; Tretiakova M; Yang C; Antic T; Dahi F; Shalhav AL; Karczmar G; Stadler WM
    Radiology; 2010 Dec; 257(3):715-23. PubMed ID: 20843992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology.
    Yoshimitsu K; Kiyoshima K; Irie H; Tajima T; Asayama Y; Hirakawa M; Ishigami K; Naito S; Honda H
    J Magn Reson Imaging; 2008 Jan; 27(1):132-9. PubMed ID: 18050334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics.
    Chatterjee A; Watson G; Myint E; Sved P; McEntee M; Bourne R
    Radiology; 2015 Dec; 277(3):751-62. PubMed ID: 26110669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
    Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
    J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.